Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer
Date:4/23/2009

NEW YORK, April 23 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced the appointment of Michael P. Tarnok to be its interim Chairman and Chief Executive Officer, replacing Michael S. Weiss, effective immediately.

Mr. Tarnok, age 54, has served on Keryx's Board of Directors since September 2007. Mr. Tarnok spent the majority of his career at Pfizer Inc., which he joined in 1989 as Finance Director -- US Manufacturing. From 2000-2007, Mr. Tarnok served as Senior Vice President, Finance in Pfizer's US Pharmaceuticals Division. In this position, Mr. Tarnok handled all finance responsibilities for the division, including contracting, trade management, forecasting of significant product launches and Sarbanes-Oxley compliance. Prior to joining Pfizer, Mr. Tarnok worked primarily in financial disciplines for ITT Rayonier, Inc., Celanese Corporation and Olivetti Corporation of America.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, or ESRD. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathw
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
2. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
3. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
4. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals Announces Additions to Management Team
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... CARLSBAD, Calif. , June 19, 2013 /PRNewswire/ ... soil, plant, stool and other challenging microbial nucleic ... Soil Protein Extraction Kit, for extraction of pure ... the protein world coincides with the 20 th ... ever growing innovation capabilities. (Photo: ...
(Date:6/19/2013)... 2013 Today DuPont Executive Vice President ... become leaders in the greatest challenge facing our time ... 2050. Borel spoke at the International Food ... about urgent need for students to contribute their time ... sustainable and reached in collaboration with others. , “Food ...
(Date:6/19/2013)... 2013 India’s vast and growing ... be worth up to a billion dollars per ... government is taking serious action to better regulate ... This presentation will examine:, ,     Recent ...     Immediate and long term impacts ,     Foreseeable ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Adding to ... is now stocked with Simport’s Dropette® and Heathrow ... at the customer doing basic biology, chemistry and any ... serology). , For over 35 years, Simport has been ... labware - products like the Simport Dropette®. Simport’s Dropette® ...
Breaking Biology Technology:MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil 2DuPont Leader Calls for New Generation of Food Visionaries to Fight Hunger 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2
... 2 MannKind Corporation (Nasdaq: MNKD ), ... and cancer, announced today that it will present at ... Investor Conference on Monday, February 9, 2009 at 2:15 ... York City. In addition to this presentation, ...
... Since the cloning of Dolly the Sheep over ... considered a promising way to generate human, patient-specific stem cells ... led to efforts to substitute animal oocytes. However, a new ... Number 2, 2009 issue of Cloning and Stem Cells ...
... for healthcare applications, Polymer Science perfects its adhesive ... will introduce a new line of silicone gel ... 10-12 in Anaheim, California. To meet the ... contact applications, Polymer Science has developed three new ...
Cached Biology Technology:MannKind to Present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor Conference 2Animal Eggs Not Suitable Substitutes to Produce Stem Cells 2Animal Eggs Not Suitable Substitutes to Produce Stem Cells 3Polymer Science Releases New Silicone Gel Adhesive Products for MD&M West 2
(Date:6/18/2013)... Scientists at the University of Calgary,s Faculty of Medicine ... the body from harmful bacteria. Platelets, a component of ... search for specific bacteria, and upon detection, seal it ... which were published in Nature Immunology this ... of immunity. , "The science community has known that ...
(Date:6/18/2013)... a very large "dead zone" in the Gulf of ... the Chesapeake Bay this year, based on several NOAA-supported ... Michigan, Louisiana State University, and the Louisiana Universities ... Mexico hypoxic "dead" zone will be between 7,286 and ... ten largest recorded. That would range from an area ...
(Date:6/18/2013)... June 18, 2013: The Association for Molecular Pathology is ... American Societies for Experimental Biology (FASEB) on July 1, ... on June 3, 2013. , The 26 constituent ... share a common vision for the advancement of research ... and translational research is more important now than ever," ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4
... have developed a brain implant that essentially melts into place, ... pave the way for better devices to monitor and control ... parts of the spinal cord. "These implants have the ... while minimizing damage to the brain. They could provide ...
... CINCINNATIThe American Cancer Society estimates one man in six ... second-leading cause of cancer death in men. With a new ... of a new drug in stopping the growth of prostate ... lab of Zhongyun Dong, PhD, will test the efficacy of ...
... that they have found a way to determine which somatic ... reprogrammed into a primordial, embryonic-like state are the most viable ... week by the Journal of Biological Chemistry, two ... point to a marker they found in induced-pluripotent stem cells, ...
Cached Biology News:A brain-recording device that melts into place 2A brain-recording device that melts into place 3UC to test targeted treatment for prostate cancer 2Chinese scientists discover marker indicating the developmental potential of stem cells 2
... except that it uses a deep-UV deuterium bulb, ... comes with a shutter (controlled via a TTL ... The DH-2000 Deuterium Tungsten Halogen Light Source ... halogen light sources in a single optical path. ...
... The LUMIstar OPTIMA is a fully ... designed for the widest possible range ... Reporter gene assays luciferase, -galactosidase, ... acridinium esters, dioxetanes..) Luminescent Immunoassays ...
One controller two vessel system suitable for early stage of fermentation, and small scale, Application : cultivation of microorganisms and human or animal cells...
... Quidel's depleted sera are specifically depleted ... exception of the depleted protein, the alternative ... reagents are therefore ideal for the detection ... ,Depleted sera have been used to assess ...
Biology Products: